Drug intelligence / Profile preview

ketorolac + prednisolone acetate

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Ophthalmic
01

Overview

Ketorolac + prednisolone acetate is a fixed-dose combination of two ophthalmic agents used primarily for the treatment and prevention of inflammation and pain following ocular surgery, as well as for other inflammatory eye conditions. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting prostaglandin synthesis through non-selective inhibition of cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing inflammation and pain[4][8]. Prednisolone acetate is a synthetic glucocorticoid corticosteroid that acts as an anti-inflammatory and immunosuppressive agent by binding to the glucocorticoid receptor, modulating gene expression, suppressing leukocyte infiltration at sites of inflammation, interfering with mediators of inflammatory response, and reducing edema[5]. The combination therapy offers additive or synergistic effects in controlling postoperative ocular inflammation compared to monotherapy[3].

Brand names
Acular + Pred ForteAcuvail + Pred ForteAcular LS + Pred Mild
Other names
ketorolac tromethamine + prednisolone acetate
02

Targets

GR (Glucocorticoid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ketorolac + prednisolone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketorolac + prednisolone acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call